Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-MCBS Scorecards

ESMO MCBS  1000x150

The searchable portal provides a centralised location of cancer medicines that have been scored and published by ESMO.

The ESMO-MCBS Scorecards

The ESMO-MCBS Scorecards allows you to filter either by Agent, Tumour or Score giving priority to different criteria such as Agent and Tumour Type and Tumour sub-type and Tumour sub-group in the Curative or Non-curative setting. This content will be updated regularly and communicated to ESMO Members.

Tested Agent(s) Combined Agent(s) Control Arm Treatment Setting Tumour Type Tumour Sub-type Tumour Sub-group Tumour Stage Score Ref. Scorecard
Ramucirumab FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) + placebo 2nd line treatment after bevacizumab, oxaliplatin, fluoropyrimidine Gastrointestinal Cancers Colon and Rectal Cancer - Metastatic
1
Bevacizumab FOLFOX4 (oxaliplatin, folinic acid, 5-fluorouracil) FOLFOX4 (oxaliplatin, folinic acid, 5-fluorouracil) 2nd line treatment after FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) Gastrointestinal Cancers Colon and Rectal Cancer - Metastatic
3
Panitumumab - Best supportive care 3rd line metastatic Gastrointestinal Cancers Colon and Rectal Cancer RAS-WT Metastatic
3
Oxaliplatine 5FU, Irinotecan, Bevacizumab FOLFIRI bevacizumab 1st line metastatic Gastrointestinal Cancers Colon and Rectal Cancer - Metastatic
2
Trifluiridine/tipiracil (TAS-102) - Placebo 3rd line metastatic CRC Gastrointestinal Cancers Colon and Rectal Cancer - Metastatic
2
Regorafenib - Placebo 3rd line metastatic Gastrointestinal Cancers Colon and Rectal Cancer - Metastatic
1
Aflibercept FOLFIRI FOLFIRI + placebo 2nd line after oxaliplatin based treatment Gastrointestinal Cancers Colon and Rectal Cancer - Metastatic
1
Bevacizumab Chemotherapy Chemotherapy 2nd line beyond progression on bevacizumab Gastrointestinal Cancers Colon and Rectal Cancer - Metastatic
1
Epirubicin, 5FU, Cisplatin - Surgery Peri-operative Gastrointestinal Cancers Oesophageal or Gastric Cancer - Early
A
5FU, Cisplatin - Surgery Peri-operative Gastrointestinal Cancers Oesophageal or Gastric Cancer - Early
A

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings